Discover findings from a study on radiotherapy use for colorectal cancer in Indonesia. Analysis of 3,330 patients presented at #ESTROAsia24 reveals gaps between optimal and actual radiotherapy rates, highlighting unmet needs in cancer care. 👉 https://bit.ly/48DpGdE Soehartati Gondhowiardjo Vito Filbert J. #Radiotherapy #ColorectalCancer #CancerCare
European Society for Radiotherapy and Oncology (ESTRO)’s Post
More Relevant Posts
-
A 2023 study published in "Integrative Cancer Therapies" examined reflexology's effectiveness in reducing fatigue in patients undergoing radiotherapy. Results showed that reflexology was effective in reducing fatigue, and they recommend simple and low cost non-pharmacological interventions like this should be widely performed to decrease the side effects of radiotherapy among cancer patients. Read the complete study: https://lnkd.in/gUgkvBGE #WeAreNHPC #HolisticHealth #Reflexology #MedicalResearch #CancerResearch #NaturalTherapies #HealthAndWellness
-
-
Important Data & Even more important comment by Matthias Guckenberger Radiotherapy is frequently framed as toxic treatment with relevant side effects - oncological drugs are frequently framed as soft / less toxic / specific etc etc
Remember the misleading press reports about "brutal" #radonc after PROSPECT ? This is what modern radiotherapy can achieve for elderly breast cancer patients ! 👉 "Endocrine Tx was associated with a greater reduction in HRQOL compared with RT at 24 mo" 👉 oncological data awaited Huge congratulations to Icro Meattini and the EUROPA study team !!!
-
-
📌 Key Information About the European Society for Radiotherapy and Oncology (ESTRO) Learn how ESTRO is revolutionizing cancer care with innovative radiotherapy techniques, including proton therapy and AI-enhanced treatment planning. Dive into valuable insights from their congresses, research initiatives, and educational programs. For detailed info, visit: https://lnkd.in/euazdzsh #ESTRO24 #CancerCare #Radiotherapy #OncoDaily #Oncology #Cancer #Health #Medicine
-
-
#ProstateCancer #SurvivalRate with #RadialConformalRadiotherapy was analyzed in the #HealthResearchPeaper titled "Results with radical conformal radiotherapy in prostate cancer". The authors concluded that Radial Conformal Radiotherapy had good control rates of Prostate Cancer. #ClinicalResearch #Research #Health #Prostate #Cancer #Radiotherapy #CIHRHJM #FreeFullText Read the free full text in Clinical Innovations in Health Research-HJM: https://lnkd.in/eHBq5gCM
-
Radiotherapy should be recommended for patients with metastatic castration-sensitive Prostate Cancer, summarized by Gustavo Viani https://lnkd.in/d3PNs2Mg Alberto BOSSI Stéphanie Foulon Xavier Maldonado Paul Sargos, MD Ray McDermott Paul Kelly Hélène RIBAULT Jihane Boustani Gustave Roussy #Cancer #CancerResearch #ProstateCancer #Radiotherapy #CancerTreatment #Medicine #Health #Oncology #OncoDaily
-
-
📚 Proud to announce the publication of my latest article: "Tumor Hypoxia and Radioresistance" 🧬This review explores the complex relationship between tumor hypoxia and its impact on radiotherapy outcomes, offering insights into potential therapeutic strategies to improve treatment effectiveness. It’s a topic close to my heart, as advancing cancer care and patient outcomes remain my top priority.🔗 https://lnkd.in/d3AWACtN #TumorHypoxia #Radiotherapy #Oncology #CancerResearch
-
-
📃 The prognostic significance of sarcopenia in patients treated with definitive radiotherapy: A systematic review. Sarcopenia impacts cancer treatment outcomes. Our review highlights its mixed prognostic significance in radiotherapy patients. 💪📉 https://lnkd.in/dXPKRA3i
-
China's Approach and Practice of Radiotherapy for Rectal Cancer in the Precision Medicine Era: Presented by Dr. Jing Jin during the Global Cancer Movement: Challenging the Status Quo Join us by the link below: https://lnkd.in/dNgP7N6U #Cancer #CancerResearch #ColorectalCancer #GlobalCancerMovement #RectalCancer #CancerTreatment #Radiotherapy #Medicine #Health #Oncology #OncoDaily
-
-
🚨Highlights from ESMO 2024! Dr Michael Saerens, medical oncologist at University Hospital Ghent, shares key findings from recent clinical trials in head & neck cancer, including: - Weekly cisplatin shows non-inferiority with fewer side effects in SCCHN. - GORTEC REACH trial shows no added benefit of avelumab, cetuximab, and radiotherapy. - Setanaxib combined with pembrolizumab offers improved survival in recurrent/metastatic SCCHN. Discover these updates.👇 For all ESMO 2024 videos, find the link in the comments! #MediMix #ESMO2024 #Oncology #HeadAndNeckCancer #ClinicalTrials #Immunotherapy
-
Assertive Health & Life Science Visionary | Diagnostic and Biotech Sales Executive | Strategic Go-to-Market Expert
Here is some news you can use that may help address new questions you may ask the next time you have some form of radiation to assist in diagnosing if there is something abnormal there, what exactly is it, how severe is it, and what should i know before accepting a treatment plan? #adaptiveradiotherapy
Personalizing care with adaptive therapy is an important step toward a world without fear of cancer. As part of Siemens Healthineers, Varian is proud to provide adaptive radiotherapy systems that integrate intelligent and image-guided technologies to precisely tailor advanced radiotherapy treatments, allowing us to move farther away from one-size-fits-all treatment delivery. This is especially important for prostate cancer, because the tumor can change shape and location each day depending surrounding anatomy. #getchecked #teamhealthineers
Commercial Leader | Medical Device | Digital Healthcare
4moWay to go Prof Tati and Vito Filbert Jayalie !